Navigation Links
Bionovo Announces Presentation at the National Cancer Institute
Date:2/4/2009

EMERYVILLE, Calif., Feb. 4 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI) today announced that company researchers will be presenting at the National Cancer Institute's Office of Cancer Complementary and Alternative Medicine's (OCCAM) monthly lecture series. The title of the presentation is "Selective Cytotoxic Activity of BZL 101 Towards Cancer Cells and Anti-Tumor Effects in Patients with Advanced Breast Cancer," and will be presented by Dr. Emma Shtivelman, Bionovo's Director of Cancer Research, and Dr. Mary Tagliaferri, Bionovo's President and Chief Medical Officer.

Dr. Emma Shtivelman earned her Ph.D. in molecular biology from the Weizmann Institute of Science, Israel. She was a postdoctoral associate at the G.W. Hooper Research Foundation University of California, San Francisco. She is the recipient of several awards including J. F. Kennedy Prize of Excellence and the Israeli Parliament Award for Excellence in Studies. Dr. Shtivelman has patents resulting from her work.

Dr. Mary Tagliaferri, a graduate from Cornell University, received her medical degree from the University of California, San Francisco. She also holds a master's degree in Traditional Chinese Medicine from the American College of Traditional Chinese Medicine.

Dr. Tagliaferri has over 13 years experience in translational research with the University of California, San Francisco and Bionovo, Inc. Dr. Tagliaferri has spearheaded multiple scientific R & D projects to develop pharmaceutical agents for indications in women's health and cancer. As one of the co-founders of Bionovo Inc, she has extensive experience with FDA regulatory affairs, and she has successfully filed a number of Investigational New Drug Licenses (INDs). She has been involved in all aspects of drug dev
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Bionovo Announces Cost Control Measures Taken
2. Willa A. Hsueh, M.D., Joins Bionovos Scientific Advisory Board
3. Bionovo to Present Recent Findings of BN108, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium
4. Bionovo to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
5. John D. Baxter, M.D. Joins Bionovos Board of Directors
6. Bionovo to Present at the Cambria Capital Investor Meeting
7. Bionovo Announces 2007 Financial Results and Highlights
8. Bionovo Describes a New Class of Therapeutic Compounds
9. Bionovo Announces Closing of Public Offering of Common Stock
10. Kensey Nash Announces Director Resignation
11. USP announces new standards to protect patients from counterfeit and adulterated medicines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 In honor of women everywhere, ... providing information that women can use to improve their ... women should pay close attention to their health, as ... changes a woman’s body undergoes while pregnant can increase ... says Dr. Ray Workman, a leading vein doctor at ...
(Date:6/19/2013)... Washington, DC (PRWEB) June 19, 2013 ... experiment in the history of managed care. As ... find coverage through the new state-based and federally ... requirements for essential health benefits, and examples of ... some states, industry-leading health business information publisher Atlantic ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Scott Tischler of ... curb this swim suit season. , 1.    The very first thing ... big tall glass of ice cold water. The body is ... water. This will keep the body hydrated and will also ... body has to raise the temperature of the water to ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 As Mirena ... LLP highlights a recent news story from an NBC ... effects of the hormone-based contraceptive device. The Rottenstein Law ... to file Mirena lawsuits and who are ... The U.S. Food and Drug Administration has logged more ...
(Date:6/19/2013)... Transvaginal mesh lawsuits are moving along in the New ... how to handle evidence in the C.R. Bard lawsuits, specifically ... components removed from patients. The Rottenstein Law Group LLP maintains ... about the device and a guide on how to file ... the medical facilities that currently hold them and are to ...
Breaking Medicine News(10 mins):Health News:Novant Health Vein Specialists Promotes Women’s Health with Social Media Campaign 2Health News:New Special Report Provides Comprehensive Overview of New Health Insurance Exchange Marketplaces 2Health News:Rottenstein Law Group LLP Comments on News Reports of Mirena IUD Side Effects 2Health News:Transvaginal Mesh Lawsuit News: NJ Mesh Consolidation Cases Moving Along, Rottenstein Law Group LLP Reports 2
... Mich., April 3 Recently, researchers at the ... Business conducted a study of U.S. hospitals and discovered ... a year. The study recommended solutions, including location-based technology, ... results of this study come at a time when ...
... Bertalan Mesko, medical blogger and health 2.0 consultant ... The Netherlands at a Health 2.0 event where he focused ... E-patients are patients who communicate with their doctors via webcam ... are more up-to-date than their own doctors because they use ...
... President of the California Association of Health Underwriters ... today to join him in demanding that Congress ... health care reform in the partisan environment of ... of Health Underwriters, the California Association insists that ...
... neurodegenerative disease , , FRIDAY, April 3 (HealthDay News) -- ... prevent brain cells from falling victim to the ravages ... the preliminary stages, and the researchers don,t know if ... disease expert said the findings could lead to a ...
... computer based model that aids them in discriminating between ... performed at the University Of Wisconsin School of Medicine, ... group, including radiologists and industrial engineers, led by Elizabeth ... PhD. , "The computer based model ...
... Boston University School of Medicine,s (BUSM) New England ... with healthy aging and longevity amongst the children ... with scientists from the National Institute on Aging. ... Journal of the American Geriatrics Society . ...
Cached Medicine News:Health News:Versus Technology to Showcase Leading Enterprise Patient and Clinical Workflow Solutions at HIMSS 2009 2Health News:Versus Technology to Showcase Leading Enterprise Patient and Clinical Workflow Solutions at HIMSS 2009 3Health News:Versus Technology to Showcase Leading Enterprise Patient and Clinical Workflow Solutions at HIMSS 2009 4Health News:Scientists Uncover New Weapon Against Huntington's 2Health News:Computer based model helps radiologists diagnose breast cancer 2Health News:Researchers identify personality traits 2
(Date:6/18/2013)... , June 18, 2013  Isis Pharmaceuticals, Inc. (NASDAQ: ... that management will present a general corporate update in conjunction ... on Tuesday, June 25 at 2:10 p.m. Pacific Time in ... for the meeting is as follows: 2:00 p.m. – 2:10 ... as of April 26, 2013) 2:10 p.m. – 3:15 p.m. ...
(Date:6/17/2013)... WASHINGTON , June 17, 2013 ... ) presented additional data today at ENDO 2013, ... demonstrating that tasimelteon can entrain (synchronize) both melatonin ... potential to reset the master body clock and ... Non-24-Hour Disorder (Non-24).  The SET (Safety and Efficacy ...
(Date:6/17/2013)... June 17, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... it has filed a preliminary prospectus supplement to its effective ... a similar filing with securities regulatory authorities in each of ... with a public offering of its common shares to raise ... The Company will also grant to the underwriters of the ...
Breaking Medicine Technology:Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4
... collect sample, pipette into testing wells ... FDA 510K cleared multiple drug screen ... both drugs and adulterants. It can ... (5) drugs and can be accompanied ...
... Glucose Monitoring System is a patient insertable short-term ... the DexCom STS Receiver., The DexCom STS Sensor ... the DexCom STS Applicator by the user or ... held in place by an adhesive to the ...
... routine Holter,monitoring, the Burdick Vision ... a,practical, no-nonsense diagnostic tool ideal,for ... This highly accurate and,easy-to-use system ... configurations at a price even ...
... PC-based ECG diagnostics complements transition to ... the incorporation of computer-based technology into ... diagnostic instrumentation have developed. Burdick's Universal ... EMRs making it the ideal choice ...
Medicine Products: